Medicine
from24/7 Wall St.
13 hours agoThese 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.